<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33925016</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Histone Methylation Regulation in Neurodegenerative Disorders.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4654</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22094654</ELocationID><Abstract><AbstractText>Advances achieved with molecular biology and genomics technologies have permitted investigators to discover epigenetic mechanisms, such as DNA methylation and histone posttranslational modifications, which are critical for gene expression in almost all tissues and in brain health and disease. These advances have influenced much interest in understanding the dysregulation of epigenetic mechanisms in neurodegenerative disorders. Although these disorders diverge in their fundamental causes and pathophysiology, several involve the dysregulation of histone methylation-mediated gene expression. Interestingly, epigenetic remodeling via histone methylation in specific brain regions has been suggested to play a critical function in the neurobiology of psychiatric disorders, including that related to neurodegenerative diseases. Prominently, epigenetic dysregulation currently brings considerable interest as an essential player in neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Amyotrophic lateral sclerosis (ALS) and drugs of abuse, including alcohol abuse disorder, where it may facilitate connections between genetic and environmental risk factors or directly influence disease-specific pathological factors. We have discussed the current state of histone methylation, therapeutic strategies, and future perspectives for these disorders. While not somatically heritable, the enzymes responsible for histone methylation regulation, such as histone methyltransferases and demethylases in neurons, are dynamic and reversible. They have become promising potential therapeutic targets to treat or prevent several neurodegenerative disorders. These findings, along with clinical data, may provide links between molecular-level changes and behavioral differences and provide novel avenues through which the epigenome may be targeted early on in people at risk for neurodegenerative disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Basavarajappa</LastName><ForeName>Balapal S</ForeName><Initials>BS</Initials><Identifier Source="ORCID">0000-0002-4429-8078</Identifier><AffiliationInfo><Affiliation>Division of Analytical Psychopharmacology, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York State Psychiatric Institute, New York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, College of Physicians &amp; Surgeons, Columbia University, New York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York University Langone Medical Center, Department of Psychiatry, New York, NY 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbanna</LastName><ForeName>Shivakumar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Analytical Psychopharmacology, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AA019443</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AA019443</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042421" MajorTopicYN="N">Histone Code</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008745" MajorTopicYN="N">Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Huntington&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">neuronal loss and alcohol</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33925016</ArticleId><ArticleId IdType="pmc">PMC8125694</ArticleId><ArticleId IdType="doi">10.3390/ijms22094654</ArticleId><ArticleId IdType="pii">ijms22094654</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Basavarajappa B.S., Shivakumar M., Joshi V., Subbanna S. Endocannabinoid system in neurodegenerative disorders. J. Neurochem. 2017;142:624&#x2013;648. doi: 10.1111/jnc.14098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14098</ArticleId><ArticleId IdType="pmc">PMC5669051</ArticleId><ArticleId IdType="pubmed">28608560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R., Kapogiannis D., Huey E.D., Momeni P. FTD and ALS: A tale of two diseases. Curr. Alzheimer Res. 2011;8:273&#x2013;294. doi: 10.2174/156720511795563700.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511795563700</ArticleId><ArticleId IdType="pmc">PMC3801195</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson S.B., Figueroa K.P., Bromberg M.B., Pulst S.M., Cannon-Albright L. Familial clustering of ALS in a population-based resource. Neurology. 2014;82:17&#x2013;22. doi: 10.1212/01.wnl.0000438219.39061.da.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000438219.39061.da</ArticleId><ArticleId IdType="pmc">PMC3873619</ArticleId><ArticleId IdType="pubmed">24306004</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S., Al Khleifat A., Al-Chalabi A. What causes amyotrophic lateral sclerosis? F1000Research. 2017;6:371. doi: 10.12688/f1000research.10476.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.10476.1</ArticleId><ArticleId IdType="pmc">PMC5373425</ArticleId><ArticleId IdType="pubmed">28408982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hely M.A., Morris J.G., Reid W.G., Trafficante R. Sydney Multicenter Study of Parkinson&#x2019;s disease: Non-L-dopa-responsive problems dominate at 15 years. Mov. Disord. 2005;20:190&#x2013;199. doi: 10.1002/mds.20324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.20324</ArticleId><ArticleId IdType="pubmed">15551331</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid W.G., Hely M.A., Morris J.G., Loy C., Halliday G.M. Dementia in Parkinson&#x2019;s disease: A 20-year neuropsychological study (Sydney Multicentre Study) J. Neurol. Neurosurg. Psychiatry. 2011;82:1033&#x2013;1037. doi: 10.1136/jnnp.2010.232678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.232678</ArticleId><ArticleId IdType="pubmed">21335570</ArticleId></ArticleIdList></Reference><Reference><Citation>Panza F., Lozupone M., Seripa D., Daniele A., Watling M., Giannelli G., Imbimbo B.P. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. Nat. Rev. Neurol. 2020;16:213&#x2013;228. doi: 10.1038/s41582-020-0330-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0330-x</ArticleId><ArticleId IdType="pubmed">32203398</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C., Trojanowski J.Q., Lee V.M. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 2020;16:199&#x2013;212. doi: 10.1038/s41582-020-0333-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0333-7</ArticleId><ArticleId IdType="pubmed">32203399</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S.A., Tanaz R., Cobos S.N., Torrente M.P. Epigenetics in amyotrophic lateral sclerosis: A role for histone post-translational modifications in neurodegenerative disease. Transl. Res. 2019;204:19&#x2013;30. doi: 10.1016/j.trsl.2018.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2018.10.002</ArticleId><ArticleId IdType="pmc">PMC6331271</ArticleId><ArticleId IdType="pubmed">30391475</ArticleId></ArticleIdList></Reference><Reference><Citation>Deans C., Maggert K.A. What do you mean, &#x201c;epigenetic&#x201d;? Genetics. 2015;199:887&#x2013;896. doi: 10.1534/genetics.114.173492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.114.173492</ArticleId><ArticleId IdType="pmc">PMC4391566</ArticleId><ArticleId IdType="pubmed">25855649</ArticleId></ArticleIdList></Reference><Reference><Citation>Jablonka E., Lamb M.J. Epigenetic inheritance. In: Baltes P.B., Smelser N.J., editors. International Encyclopedia of the Social &amp; Behavioral Sciences. Pergamon; Oxford, UK: 2001. pp. 4706&#x2013;4710.</Citation></Reference><Reference><Citation>Burggren W. Epigenetic Inheritance and Its Role in Evolutionary Biology: Re-Evaluation and New Perspectives. Biology. 2016;5:24. doi: 10.3390/biology5020024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology5020024</ArticleId><ArticleId IdType="pmc">PMC4929538</ArticleId><ArticleId IdType="pubmed">27231949</ArticleId></ArticleIdList></Reference><Reference><Citation>Peaston A.E., Whitelaw E. Epigenetics and phenotypic variation in mammals. Mamm. Genome. 2006;17:365&#x2013;374. doi: 10.1007/s00335-005-0180-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00335-005-0180-2</ArticleId><ArticleId IdType="pmc">PMC3906716</ArticleId><ArticleId IdType="pubmed">16688527</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavarajappa B.S., Subbanna S. Epigenetic Mechanisms in Developmental Alcohol-Induced Neurobehavioral Deficits. Brain Sci. 2016;6:12. doi: 10.3390/brainsci6020012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci6020012</ArticleId><ArticleId IdType="pmc">PMC4931489</ArticleId><ArticleId IdType="pubmed">27070644</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Langley B., Lubin F.D., Renthal W., Wood M.A., Yasui D.H., Kumar A., Nestler E.J., Akbarian S., Beckel-Mitchener A.C. Epigenetics in the nervous system. J. Neurosci. 2008;28:11753&#x2013;11759. doi: 10.1523/JNEUROSCI.3797-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3797-08.2008</ArticleId><ArticleId IdType="pmc">PMC3844836</ArticleId><ArticleId IdType="pubmed">19005036</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger K., Dechassa M.L., Tremethick D.J. New insights into nucleosome and chromatin structure: An ordered state or a disordered affair? Nat. Rev. Mol. Cell. Biol. 2012;13:436&#x2013;447. doi: 10.1038/nrm3382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3382</ArticleId><ArticleId IdType="pmc">PMC3408961</ArticleId><ArticleId IdType="pubmed">22722606</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolle M., Workman J.L. Transcription-associated histone modifications and cryptic transcription. Biochim. Biophys. Acta. 2013;1829:84&#x2013;97. doi: 10.1016/j.bbagrm.2012.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2012.08.008</ArticleId><ArticleId IdType="pmc">PMC5854953</ArticleId><ArticleId IdType="pubmed">22982198</ArticleId></ArticleIdList></Reference><Reference><Citation>Barski A., Cuddapah S., Kairong C., Roh T.-Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129:823&#x2013;837. doi: 10.1016/j.cell.2007.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.05.009</ArticleId><ArticleId IdType="pubmed">17512414</ArticleId></ArticleIdList></Reference><Reference><Citation>Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Calcar S.V., Qu C., Ching K.A., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007;39:311&#x2013;318. doi: 10.1038/ng1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1966</ArticleId><ArticleId IdType="pubmed">17277777</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X., Hong T., Walter K.L., Ewalt M., Michishita E., Hung T., Carney D., Pena P., Lan F., Kaadige M.R., et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature. 2006;442:96&#x2013;99. doi: 10.1038/nature04835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04835</ArticleId><ArticleId IdType="pmc">PMC3089773</ArticleId><ArticleId IdType="pubmed">16728974</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X., Kachirskaia I., Walter K.L., Kuo J.-H.A., Lake A., Davrazou F., Chan S.M., Martin D.G.E., Fingerman I.M., Briggs S.D., et al. Proteome-wide analysis in Saccharomyces cerevisiae identifies several PHD fingers as novel direct and selective binding modules of histone H3 methylated at either lysine 4 or lysine 36. J. Biol. Chem. 2007;282:2450&#x2013;2455. doi: 10.1074/jbc.C600286200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C600286200</ArticleId><ArticleId IdType="pmc">PMC2735445</ArticleId><ArticleId IdType="pubmed">17142463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysocka J., Swigut T., Xiao H., Milne T.A., Kwon S.Y., Landry J., Kauer M., Tackett A.J., Chait B.T., Badenhorst P., et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature. 2006;442:86&#x2013;90. doi: 10.1038/nature04815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04815</ArticleId><ArticleId IdType="pubmed">16728976</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao B., Jing C., Wilson J.R., Walker P.A., Vasisht N., Kelly G., Howell S., Taylor I.A., Blackburn G.M., Gamblin S.J. Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature. 2003;421:652&#x2013;656. doi: 10.1038/nature01378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01378</ArticleId><ArticleId IdType="pubmed">12540855</ArticleId></ArticleIdList></Reference><Reference><Citation>Allis C.D., Berger S.L., Cote J., Dent S., Jenuwien T., Kouzarides T., Pillus L., Reinberg D., Shi Y., Shiekhattar R., et al. New nomenclature for chromatin-modifying enzymes. Cell. 2007;131:633&#x2013;636. doi: 10.1016/j.cell.2007.10.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.039</ArticleId><ArticleId IdType="pubmed">18022353</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian C., Zhou M.M. SET domain protein lysine methyltransferases: Structure, specificity and catalysis. Cell. Mol. Life Sci. 2006;63:2755&#x2013;2763. doi: 10.1007/s00018-006-6274-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-006-6274-5</ArticleId><ArticleId IdType="pubmed">17013555</ArticleId></ArticleIdList></Reference><Reference><Citation>Aravind L., Abhiman S., Iyer L.M. Natural history of the eukaryotic chromatin protein methylation system. Prog. Mol. Biol. Transl. Sci. 2011;101:105&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">21507350</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozzetta C., Boyarchuk E., Pontis J., Ait-Si-Ali S. Sound of silence: The properties and functions of repressive Lys methyltransferases. Nat. Rev. Mol. Cell. Biol. 2015;16:499&#x2013;513. doi: 10.1038/nrm4029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm4029</ArticleId><ArticleId IdType="pubmed">26204160</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser S., Shaft J., Lubitz S., Vintersten K., van der Hoeven F., Tufteland K.R., Aasland R., Anastassiadis K., Ang S.-L., Stewart A.F. Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development. Development. 2006;133:1423&#x2013;1432. doi: 10.1242/dev.02302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.02302</ArticleId><ArticleId IdType="pubmed">16540515</ArticleId></ArticleIdList></Reference><Reference><Citation>Goo Y.H., Sohn Y.C., Kim D.H., Kim S.W., Kang M.J., Jung D.J., Kwak E., Barlev N.A., Berger S.L., Chow V.T., et al. Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins. Mol. Cell. Biol. 2003;23:140&#x2013;149. doi: 10.1128/MCB.23.1.140-149.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.23.1.140-149.2003</ArticleId><ArticleId IdType="pmc">PMC140670</ArticleId><ArticleId IdType="pubmed">12482968</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., Hess J.L. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell. 2002;10:1107&#x2013;1117. doi: 10.1016/S1097-2765(02)00741-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(02)00741-4</ArticleId><ArticleId IdType="pubmed">12453418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein B.E., Humphrey E.L., Erlich R.L., Schneider R., Bouman P., Liu J.S., Kouzarides T., Schreiber S.L. Methylation of histone H3 Lys 4 in coding regions of active genes. Proc. Natl. Acad. Sci. USA. 2002;99:8695&#x2013;8700. doi: 10.1073/pnas.082249499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.082249499</ArticleId><ArticleId IdType="pmc">PMC124361</ArticleId><ArticleId IdType="pubmed">12060701</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer E.L., Shi Y. Histone methylation: A dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 2012;13:343&#x2013;357. doi: 10.1038/nrg3173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3173</ArticleId><ArticleId IdType="pmc">PMC4073795</ArticleId><ArticleId IdType="pubmed">22473383</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters A.H., O&#x2019;Carroll D., Scherthan H., Mechtler K., Sauer S., Sch&#xf6;fer C., Weipoltshammer K., Pagani M., Lachner M., Kohlmaier A., et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell. 2001;107:323&#x2013;337. doi: 10.1016/S0092-8674(01)00542-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00542-6</ArticleId><ArticleId IdType="pubmed">11701123</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbanna S., Shivakumar M., Umapathy N.S., Saito M., Mohan P.S., Kumar A., Nixon R.A., Verin A.D., Psychoyos D., Basavarajappa B.S. G9a-Mediated Histone Methylation Regulates Ethanol-Induced Neurodegeneration in the Neonatal Mouse Brain. Neurobiol. Dis. 2013;54:475&#x2013;485. doi: 10.1016/j.nbd.2013.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.01.022</ArticleId><ArticleId IdType="pmc">PMC3656439</ArticleId><ArticleId IdType="pubmed">23396011</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachibana M., Shivakumar M., Umapathy N.S., Saito M., Mohan P.S., Kumar A., Nixon R.A., Verin A.D., Psychoyos D., Basavarajappa B.S. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes. Dev. 2002;16:1779&#x2013;1791. doi: 10.1101/gad.989402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.989402</ArticleId><ArticleId IdType="pmc">PMC186403</ArticleId><ArticleId IdType="pubmed">12130538</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachibana M., Ueda J., Fukuda M., Takeda N., Ohta T., Iwanari H., Sakihama T., Kodama T., Hamakubo T., Shinkai Y. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes. Dev. 2005;19:815&#x2013;826. doi: 10.1101/gad.1284005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1284005</ArticleId><ArticleId IdType="pmc">PMC1074319</ArticleId><ArticleId IdType="pubmed">15774718</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz D.C., Ayyanathan K., Negorev D., Maul G.G., Rauscher F.J. 3rd. SETDB1: A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes. Dev. 2002;16:919&#x2013;932. doi: 10.1101/gad.973302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.973302</ArticleId><ArticleId IdType="pmc">PMC152359</ArticleId><ArticleId IdType="pubmed">11959841</ArticleId></ArticleIdList></Reference><Reference><Citation>Strahl B.D., Grant P.A., Briggs S.D., Sun Z.W., Bone J.R., Caldwell J.A., Mollah S., Cook R.G., Shabanowitz J., Hunt D.F. Set2 is a nucleosomal histone H3-selective methyltransferase that mediates transcriptional repression. Mol. Cell. Biol. 2002;22:1298&#x2013;1306. doi: 10.1128/MCB.22.5.1298-1306.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.5.1298-1306.2002</ArticleId><ArticleId IdType="pmc">PMC134702</ArticleId><ArticleId IdType="pubmed">11839797</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Perez-Burgos L., Placek B.J., Sengupta R., Richter M., Dorsey J.A., Kubicek S., Opravil S., Jenuwein T., Berger S.L. Repression of p53 activity by Smyd2-mediated methylation. Nature. 2006;444:629&#x2013;632. doi: 10.1038/nature05287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05287</ArticleId><ArticleId IdType="pubmed">17108971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu T., Jackson M.W., Wang B., Yang M., Chance M.R., Miyagi M., Gudkov A.V., Stark G.R. Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc. Natl. Acad. Sci. USA. 2010;107:46&#x2013;51. doi: 10.1073/pnas.0912493107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0912493107</ArticleId><ArticleId IdType="pmc">PMC2806709</ArticleId><ArticleId IdType="pubmed">20080798</ArticleId></ArticleIdList></Reference><Reference><Citation>Saddic L.A., West L.E., Aslanian A., Yates J.R., 3rd, Rubin S.M., Gozani O., Sage J. Methylation of the retinoblastoma tumor suppressor by SMYD2. J. Biol. Chem. 2010;285:37733&#x2013;37740. doi: 10.1074/jbc.M110.137612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.137612</ArticleId><ArticleId IdType="pmc">PMC2988378</ArticleId><ArticleId IdType="pubmed">20870719</ArticleId></ArticleIdList></Reference><Reference><Citation>Steger D.J., Lefterova M.I., Ying L., Stonestrom A.J., Schupp M., Zhuo D., Vakoc A.L., Kim J.E., Chen J., Lazar M.A., et al. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol. Cell. Biol. 2008;28:2825&#x2013;2839. doi: 10.1128/MCB.02076-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.02076-07</ArticleId><ArticleId IdType="pmc">PMC2293113</ArticleId><ArticleId IdType="pubmed">18285465</ArticleId></ArticleIdList></Reference><Reference><Citation>Karachentsev D., Sarma K., Reinberg D., Steward R. PR-Set7-dependent methylation of histone H4 Lys 20 functions in repression of gene expression and is essential for mitosis. Genes. Dev. 2005;19:431&#x2013;435. doi: 10.1101/gad.1263005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1263005</ArticleId><ArticleId IdType="pmc">PMC548943</ArticleId><ArticleId IdType="pubmed">15681608</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Joshi P., Miller E.L., Higgins L., Slattery M., Simon J.A. A Role for Monomethylation of Histone H3-K27 in Gene Activity in Drosophila. Genetics. 2018;208:1023&#x2013;1036. doi: 10.1534/genetics.117.300585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.117.300585</ArticleId><ArticleId IdType="pmc">PMC5844320</ArticleId><ArticleId IdType="pubmed">29242288</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob Y., Feng S., LeBlanc C.A., Bernatavichute Y.V., Stroud H., Cokus S., Johnson L.M., Pellegrini M., Jacobsen S.E., Michaels S.D. ATXR5 and ATXR6 are H3K27 monomethyltransferases required for chromatin structure and gene silencing. Nat. Struct. Mol. Biol. 2009;16:763&#x2013;768. doi: 10.1038/nsmb.1611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1611</ArticleId><ArticleId IdType="pmc">PMC2754316</ArticleId><ArticleId IdType="pubmed">19503079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Molascon A.J., Gao S., Liu Y., Andrews P.C. Quantitative proteomics reveals that the specific methyltransferases Txr1p and Ezl2p differentially affect the mono-, di- and trimethylation states of histone H3 lysine 27 (H3K27) Mol. Cell. Proteomics. 2013;12:1678&#x2013;1688. doi: 10.1074/mcp.M112.021733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M112.021733</ArticleId><ArticleId IdType="pmc">PMC3675822</ArticleId><ArticleId IdType="pubmed">23150054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.G., Villa R., Trojer P., Norman J., Yan K.P., Reinberg D., Di Croce L., Shiekhattar R. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science. 2007;318:447&#x2013;450. doi: 10.1126/science.1149042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1149042</ArticleId><ArticleId IdType="pubmed">17761849</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund A.H., van Lohuizen M. Polycomb complexes and silencing mechanisms. Curr. Opin. Cell. Biol. 2004;16:239&#x2013;246. doi: 10.1016/j.ceb.2004.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2004.03.010</ArticleId><ArticleId IdType="pubmed">15145347</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte A.P., Kwaks T.H. Gene repression by Polycomb group protein complexes: A distinct complex for every occasion? Curr. Opin. Genet. Dev. 2003;13:448&#x2013;454. doi: 10.1016/S0959-437X(03)00108-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-437X(03)00108-4</ArticleId><ArticleId IdType="pubmed">14550408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccone D.N., Su H., Hevi S., Gay F., Lei H., Bajko J., Xu G., Li E., Chen T. KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature. 2009;461:415&#x2013;418. doi: 10.1038/nature08315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08315</ArticleId><ArticleId IdType="pubmed">19727073</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L., Hanigan C.L., Wu Y., Wang W., Park B.H., Woster P.M., Casero R.A. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner. Biochem. J. 2013;449:459&#x2013;468. doi: 10.1042/BJ20121360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20121360</ArticleId><ArticleId IdType="pmc">PMC3525012</ArticleId><ArticleId IdType="pubmed">23072722</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Essen D., Zhu Y., Saccani S. A feed-forward circuit controlling inducible NF-kappaB target gene activation by promoter histone demethylation. Mol. Cell. 2010;39:750&#x2013;760. doi: 10.1016/j.molcel.2010.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.08.010</ArticleId><ArticleId IdType="pubmed">20832726</ArticleId></ArticleIdList></Reference><Reference><Citation>Seward D.J., Cubberley G., Kim S., Schonewald M., Zhang L., Tripet B., Bentley D.L. Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins. Nat. Struct. Mol. Biol. 2007;14:240&#x2013;242. doi: 10.1038/nsmb1200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1200</ArticleId><ArticleId IdType="pubmed">17310255</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Y., Zhu Z., Han G., Ye X., Xu B., Peng Z., Ma Y., Yu Y., Lin H., Chen A.P. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl. Acad. Sci. USA. 2007;104:19226&#x2013;19231. doi: 10.1073/pnas.0700735104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0700735104</ArticleId><ArticleId IdType="pmc">PMC2148272</ArticleId><ArticleId IdType="pubmed">18048344</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada Y., Fang J., Erdjument-Bromage H., Warren M.E., Borchers C.H., Tempst P., Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2006;439:811&#x2013;816. doi: 10.1038/nature04433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04433</ArticleId><ArticleId IdType="pubmed">16362057</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamane K., Toumazou C., Tsukada Y., Erdjument-Bromage H., Tempst P., Wong J., Zhang Y. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell. 2006;125:483&#x2013;495. doi: 10.1016/j.cell.2006.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.03.027</ArticleId><ArticleId IdType="pubmed">16603237</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodor B.D., Kubicek S., Yonezawa M., O&#x2019;Sullivan R.J., Sengupta R., Perez-Burgos L., Opravil S., Mechtler K. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes. Dev. 2006;20:1557&#x2013;1562. doi: 10.1101/gad.388206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.388206</ArticleId><ArticleId IdType="pmc">PMC1482475</ArticleId><ArticleId IdType="pubmed">16738407</ArticleId></ArticleIdList></Reference><Reference><Citation>Klose R.J., Yamane K., Bae Y., Zhang D., Erdjument-Bromage H., Tempst P., Wong J., Zhang Y. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature. 2006;442:312&#x2013;316. doi: 10.1038/nature04853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04853</ArticleId><ArticleId IdType="pubmed">16732292</ArticleId></ArticleIdList></Reference><Reference><Citation>Whetstine J.R., Nottke A., Lan F., Huarte M., Smolikov S., Chen Z., Spooner E., Li E., Zhang G., Colaiacovo M. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell. 2006;125:467&#x2013;481. doi: 10.1016/j.cell.2006.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.03.028</ArticleId><ArticleId IdType="pubmed">16603238</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams-Cioaba M.A., Min J. Structure and function of histone methylation binding proteins. Biochem. Cell. Biol. 2009;87:93&#x2013;105. doi: 10.1139/O08-129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/O08-129</ArticleId><ArticleId IdType="pubmed">19234526</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Fang J., Bedford M.T., Zhang Y., Xu R.M. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A. Science. 2006;312:748&#x2013;751. doi: 10.1126/science.1125162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1125162</ArticleId><ArticleId IdType="pubmed">16601153</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen J., Agger K., Cloos P.A., Pasini D., Rose S., Sennels L., Rappsilber J., Hansen K.H., Salcini A.E., Helin K. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell. 2007;128:1063&#x2013;1076. doi: 10.1016/j.cell.2007.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.02.003</ArticleId><ArticleId IdType="pubmed">17320161</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwase S., Lan F., Bayliss P., de la Torre-Ubieta L., Huarte M., Qi H.H., Whetstine J.R., Bonni A., Roberts T.M., Shi Y. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell. 2007;128:1077&#x2013;1088. doi: 10.1016/j.cell.2007.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.02.017</ArticleId><ArticleId IdType="pubmed">17320160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.G., Norman J., Shilatifard A., Shiekhattar R. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell. 2007;128:877&#x2013;887. doi: 10.1016/j.cell.2007.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.02.004</ArticleId><ArticleId IdType="pubmed">17320162</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahiliani M., Mei P., Fang R., Leonor T., Rutenberg M., Shimizu F., Li J., Rao A., Shi Y. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature. 2007;447:601&#x2013;605. doi: 10.1038/nature05823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05823</ArticleId><ArticleId IdType="pubmed">17468742</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamane K., Tateishi K., Klose R.J., Fang J., Fabrizio L.A., Erdjument-Bromage H., Taylor-Papadimitriou J., Tempst P., Zhang Y. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell. 2007;25:801&#x2013;812. doi: 10.1016/j.molcel.2007.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2007.03.001</ArticleId><ArticleId IdType="pubmed">17363312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G.G., Song J., Wang Z., Dormann H.L., Casadio F., Li H., Luo J.L., Patel D.J., Allis C.D. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature. 2009;459:847&#x2013;851. doi: 10.1038/nature08036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08036</ArticleId><ArticleId IdType="pmc">PMC2697266</ArticleId><ArticleId IdType="pubmed">19430464</ArticleId></ArticleIdList></Reference><Reference><Citation>Agger K., Cloos P.A., Christensen J., Pasini D., Rose S., Rappsilber J., Canaani E., Salcini A.E., Helin K. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature. 2007;449:731&#x2013;734. doi: 10.1038/nature06145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06145</ArticleId><ArticleId IdType="pubmed">17713478</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santa F., Cloos P.A., Christensen J., Pasini D., Rose S., Rappsilber J., Issaeva I., Canaani E., Salcini A.E., Helin K. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell. 2007;130:1083&#x2013;1094. doi: 10.1016/j.cell.2007.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.08.019</ArticleId><ArticleId IdType="pubmed">17825402</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S., Broun A., Ge K. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc. Natl. Acad. Sci. USA. 2007;104:18439&#x2013;18444. doi: 10.1073/pnas.0707292104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0707292104</ArticleId><ArticleId IdType="pmc">PMC2141795</ArticleId><ArticleId IdType="pubmed">18003914</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Y., Zhu Z., Han G., Lin H., Xu L., Chen C.D. JMJD3 is a histone H3K27 demethylase. Cell Res. 2007;17:850&#x2013;857. doi: 10.1038/cr.2007.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2007.83</ArticleId><ArticleId IdType="pubmed">17923864</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba A., Ohtake F., Okuno Y., Yokota K., Okada M., Imai Y., Ni M., Meyer C.A., Igarashi K., Kanno J., et al. PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Nat. Cell. Biol. 2011;13:668&#x2013;675. doi: 10.1038/ncb2228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2228</ArticleId><ArticleId IdType="pubmed">21532585</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng W., Yonezawa M., Ye J., Jenuwein T., Grummt I. PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1/2 demethylation. Nat. Struct. Mol. Biol. 2010;17:445&#x2013;450. doi: 10.1038/nsmb.1778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1778</ArticleId><ArticleId IdType="pubmed">20208542</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortschegger K., de Graaf P., Outchkourov N.S., van Schaik F.M., Timmers H.T., Shiekhattar R. PHF8 targets histone methylation and RNA polymerase II to activate transcription. Mol. Cell. Biol. 2010;30:3286&#x2013;3298. doi: 10.1128/MCB.01520-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01520-09</ArticleId><ArticleId IdType="pmc">PMC2897584</ArticleId><ArticleId IdType="pubmed">20421419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleine-Kohlbrecher D., Christensen J., Vandamme J., Abarrategui I., Bak M., Tommerup N., Shi X., Gozani O., Rappsilber J., Salcini A.E., et al. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol. Cell. 2010;38:165&#x2013;178. doi: 10.1016/j.molcel.2010.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.03.002</ArticleId><ArticleId IdType="pmc">PMC2989439</ArticleId><ArticleId IdType="pubmed">20346720</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J., Shi G., Jia Y., Li J., Wu M., Li J., Dong S., Wong J. The X-linked mental retardation gene PHF8 is a histone demethylase involved in neuronal differentiation. Cell Res. 2010;20:908&#x2013;918. doi: 10.1038/cr.2010.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.81</ArticleId><ArticleId IdType="pubmed">20548336</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L., Sun L., Li Q., Liang J., Yu W., Yi X., Yang X., Li Y., Han X., Zhang Y., et al. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc. Natl. Acad. Sci. USA. 2011;108:7541&#x2013;7546. doi: 10.1073/pnas.1017374108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017374108</ArticleId><ArticleId IdType="pmc">PMC3088624</ArticleId><ArticleId IdType="pubmed">21502505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen H., Li J., Song T., Lu M., Kan P.Y., Lee M.G., Sha B., Shi X. Recognition of histone H3K4 trimethylation by the plant homeodomain of PHF2 modulates histone demethylation. J. Biol. Chem. 2010;285:9322&#x2013;9326. doi: 10.1074/jbc.C109.097667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C109.097667</ArticleId><ArticleId IdType="pmc">PMC2843180</ArticleId><ArticleId IdType="pubmed">20129925</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Wang Y., Li X., Wang Y., Xu L., Wang X., Sun T., Dong X., Chen L., Mao H., et al. PHF8 is a histone H3K9me2 demethylase regulating rRNA synthesis. Cell Res. 2010;20:794&#x2013;801. doi: 10.1038/cr.2010.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.75</ArticleId><ArticleId IdType="pubmed">20531378</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Tanasa B., Tyurina O.V., Zhou T.Y., Gassmann R., Liu W.T., Ohgi K.A., Benner C., Garcia-Bassets I., Aggarwal A.K., et al. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature. 2010;466:508&#x2013;512. doi: 10.1038/nature09272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09272</ArticleId><ArticleId IdType="pmc">PMC3059551</ArticleId><ArticleId IdType="pubmed">20622854</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton J.R., Upadhyay A.K., Qi H.H., Zhang X., Shi Y., Cheng X. Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases. Nat. Struct. Mol. Biol. 2010;17:38&#x2013;43. doi: 10.1038/nsmb.1753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1753</ArticleId><ArticleId IdType="pmc">PMC2849977</ArticleId><ArticleId IdType="pubmed">20023638</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi H.H., Sarkissian M., Hu G.-Q., Wang Z., Bhattacharjee A., Gordon D.B., Gonzales M., Lan F., Ongusaha P.P., Huarte M., et al. Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature. 2010;466:503&#x2013;507. doi: 10.1038/nature09261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09261</ArticleId><ArticleId IdType="pmc">PMC3072215</ArticleId><ArticleId IdType="pubmed">20622853</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Wang Y., Huang S., Wang J., Deng Z., Zhang Q., Wu W., Zhang X., Liu Z., Gong W., et al. Structural insights into a novel histone demethylase PHF8. Cell Res. 2010;20:166&#x2013;173. doi: 10.1038/cr.2010.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.8</ArticleId><ArticleId IdType="pubmed">20101266</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins B.E., Greer C.B., Coleman B.C., Sweatt J.D. Histone H3 lysine K4 methylation and its role in learning and memory. Epigenetics Chromatin. 2019;12:7. doi: 10.1186/s13072-018-0251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-018-0251-8</ArticleId><ArticleId IdType="pmc">PMC6322263</ArticleId><ArticleId IdType="pubmed">30616667</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz C., Della Rosa M., Krueger C., Gao Q., Horkai D., King M., Field L., Houseley J. Tri-methylation of histone H3 lysine 4 facilitates gene expression in ageing cells. Elife. 2018;7:e34081. doi: 10.7554/eLife.34081.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34081</ArticleId><ArticleId IdType="pmc">PMC6168286</ArticleId><ArticleId IdType="pubmed">30274593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lardenoije R., Iatrou A., Kenis G., Kompotis K., Steinbusch H.W., Mastroeni D., Coleman P., Lemere C.A., Hof P.R., Hove D.L.V.D., et al. The epigenetics of aging and neurodegeneration. Prog. Neurobiol. 2015;131:21&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6477921</ArticleId><ArticleId IdType="pubmed">26072273</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehler M.F. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog. Neurobiol. 2008;86:305&#x2013;341. doi: 10.1016/j.pneurobio.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.10.001</ArticleId><ArticleId IdType="pmc">PMC2636693</ArticleId><ArticleId IdType="pubmed">18940229</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell A.C., Roussos P., Peter C.J., Tsankova N., Akbarian S. The future of neuroepigenetics in the human brain. Prog. Mol. Biol. Transl. Sci. 2014;128:199&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4863594</ArticleId><ArticleId IdType="pubmed">25410546</ArticleId></ArticleIdList></Reference><Reference><Citation>Woldemichael B.T., Bohacek J., Gapp K., Mansuy I.M. Epigenetics of memory and plasticity. Prog. Mol. Biol. Transl. Sci. 2014;122:305&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">24484706</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A. Targeting histone-modifications in Alzheimer&#x2019;s disease. What is the evidence that this is a promising therapeutic avenue? Neuropharmacology. 2014;80:95&#x2013;102. doi: 10.1016/j.neuropharm.2014.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2014.01.038</ArticleId><ArticleId IdType="pubmed">24486385</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson K.W., Turko I.V. Histone post-translational modifications in frontal cortex from human donors with Alzheimer&#x2019;s disease. Clin. Proteomics. 2015;12:26. doi: 10.1186/s12014-015-9098-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12014-015-9098-1</ArticleId><ArticleId IdType="pmc">PMC4591557</ArticleId><ArticleId IdType="pubmed">26435705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lithner C.U., Lacor P.N., Zhao W.Q., Mustafiz T., Klein W.L., Sweatt J.D., Hernandez C.M. Disruption of neocortical histone H3 homeostasis by soluble Abeta: Implications for Alzheimer&#x2019;s disease. Neurobiol. Aging. 2013;34:2081&#x2013;2090. doi: 10.1016/j.neurobiolaging.2012.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.12.028</ArticleId><ArticleId IdType="pubmed">23582659</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma M., Dierkes T., Sajikumar S. Epigenetic regulation by G9a/GLP complex ameliorates amyloid-beta 1-42 induced deficits in long-term plasticity and synaptic tagging/capture in hippocampal pyramidal neurons. Aging Cell. 2017;16:1062&#x2013;1072. doi: 10.1111/acel.12634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12634</ArticleId><ArticleId IdType="pmc">PMC5595698</ArticleId><ArticleId IdType="pubmed">28665013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Liu A., Wang Z.J., Cao Q., Wang W., Lin L., Ma K., Zhang F., Wei J., Matas E., et al. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer&#x2019;s disease. Brain. 2019;142:787&#x2013;807. doi: 10.1093/brain/awy354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy354</ArticleId><ArticleId IdType="pmc">PMC6391616</ArticleId><ArticleId IdType="pubmed">30668640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Liu A., Li H., Feng J., Yan Z. Inhibition of Histone Methyltransferases EHMT1/2 Reverses Amyloid-beta-Induced Loss of AMPAR Currents in Human Stem Cell-Derived Cortical Neurons. J. Alzheimers. Dis. 2019;70:1175&#x2013;1185. doi: 10.3233/JAD-190190.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190190</ArticleId><ArticleId IdType="pmc">PMC6995284</ArticleId><ArticleId IdType="pubmed">31322566</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Garcidue&#xf1;as L., Herrera-Soto A., Jury N., Maher B.A., Gonz&#xe1;lez-Maciel A., Reynoso-Robles R., Ruiz-Rudolph P., van Zundert B., Varela-Nallar L. Reduced repressive epigenetic marks, increased DNA damage and Alzheimer&#x2019;s disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution. Environ. Res. 2020;183:109226. doi: 10.1016/j.envres.2020.109226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2020.109226</ArticleId><ArticleId IdType="pubmed">32045727</ArticleId></ArticleIdList></Reference><Reference><Citation>Gri&#xf1;&#xe1;n-Ferr&#xe9; C., Marsal-Garc&#xed;a L., Bellver-Sanchis A., Kondengaden S.M., Turga R.C., V&#xe1;zquez S., Pall&#xe0;s M. Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and beta-Amyloid plaques in an early-onset Alzheimer&#x2019;s disease mouse model. Aging. 2019;11:11591&#x2013;11608. doi: 10.18632/aging.102558.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102558</ArticleId><ArticleId IdType="pmc">PMC6932909</ArticleId><ArticleId IdType="pubmed">31804189</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi S., Gaiteri C., Sullivan S.E., White C.C., Tasaki S., Xu J., Taga M., Klein H.-U., Patrick E., Komashko V., et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer&#x2019;s disease. Nat. Neurosci. 2018;21:811&#x2013;819. doi: 10.1038/s41593-018-0154-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0154-9</ArticleId><ArticleId IdType="pmc">PMC6599633</ArticleId><ArticleId IdType="pubmed">29802388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Ortega K., Garcia-Esparcia P., Gil L., Lucas J.J., Ferrer I. Altered Machinery of Protein Synthesis in Alzheimer&#x2019;s: From the Nucleolus to the Ribosome. Brain Pathol. 2016;26:593&#x2013;605. doi: 10.1111/bpa.12335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12335</ArticleId><ArticleId IdType="pmc">PMC8029302</ArticleId><ArticleId IdType="pubmed">26512942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan G., Zhou W., Hu Y., Ma R., Jin S., Liu G., Jiang Q. Transcriptional Regulation of lncRNA Genes by Histone Modification in Alzheimer&#x2019;s Disease. Biomed. Res. Int. 2016;2016:3164238. doi: 10.1155/2016/3164238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/3164238</ArticleId><ArticleId IdType="pmc">PMC5086382</ArticleId><ArticleId IdType="pubmed">27822470</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.R., Smith R.G., Macdonald R., Marzi S.J., Burrage J., Troakes C., Al-Sarraj S., Mill J., Lunnon K. The histone modification H3K4me3 is altered at the ANK1 locus in Alzheimer&#x2019;s disease brain. Future Sci. 2021:7. doi: 10.2144/fsoa-2020-0161.</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/fsoa-2020-0161</ArticleId><ArticleId IdType="pmc">PMC8015672</ArticleId><ArticleId IdType="pubmed">33815817</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer M., Phipps A.J., Mitew S., Taberlay P.C., Woodhouse A. Age, but Not Amyloidosis, Induced Changes in Global Levels of Histone Modifications in Susceptible and Disease-Resistant Neurons in Alzheimer&#x2019;s Disease Model Mice. Front. Aging Neurosci. 2019;11:68. doi: 10.3389/fnagi.2019.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00068</ArticleId><ArticleId IdType="pmc">PMC6456813</ArticleId><ArticleId IdType="pubmed">31001106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastroeni D., Delvaux E., Nolz J., Tan Y., Grover A., Oddo S., Coleman P.D. Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer&#x2019;s disease. Neurobiol. Aging. 2015;36:3121&#x2013;3129. doi: 10.1016/j.neurobiolaging.2015.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.017</ArticleId><ArticleId IdType="pmc">PMC4838454</ArticleId><ArticleId IdType="pubmed">26553823</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q., Wang W., Williams J.B., Yang F., Wang Z.-J., Yan Z. Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer&#x2019;s disease. Sci Adv. 2020;6 doi: 10.1126/sciadv.abc8096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc8096</ArticleId><ArticleId IdType="pmc">PMC7725456</ArticleId><ArticleId IdType="pubmed">33298440</ArticleId></ArticleIdList></Reference><Reference><Citation>THsDCR Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington&#x2019;s disease chromosomes. The Huntington&#x2019;s Disease Collaborative. Res. Group Cell. 1993;72:971&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pubmed">8458085</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald M.E., Gines S., Gusella J.F., Wheeler V.C. Huntington&#x2019;s disease. Neuromol. Med. 2003;4:7&#x2013;20. doi: 10.1385/NMM:4:1-2:7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/NMM:4:1-2:7</ArticleId><ArticleId IdType="pubmed">14528049</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonsattel J.P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 1998;57:369&#x2013;384. doi: 10.1097/00005072-199805000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199805000-00001</ArticleId><ArticleId IdType="pubmed">9596408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi S., Tripathi T., Monziani A., Di Leva F., Biagioli M. Epigenetics of Huntington&#x2019;s Disease. Adv. Exp. Med. Biol. 2017;978:277&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">28523552</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Fischhaber P.L., Guo C., Tang T.-S. Epigenetic modifications as novel therapeutic targets for Huntington&#x2019;s disease. Epigenomics. 2014;6:287&#x2013;297. doi: 10.2217/epi.14.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi.14.19</ArticleId><ArticleId IdType="pubmed">25111483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante R.J., Kubilus J.K., Lee J., Ryu H., Beesen A., Zucker B., Smith K., Kowall N.W., Ratan R.R., Luthi-Carter R., et al. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington&#x2019;s disease mice. J. Neurosci. 2003;23:9418&#x2013;9427. doi: 10.1523/JNEUROSCI.23-28-09418.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-28-09418.2003</ArticleId><ArticleId IdType="pmc">PMC6740577</ArticleId><ArticleId IdType="pubmed">14561870</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante R.J., Ryu H., Kubilus J.K., D&#x2019;Mello S., Sugars K.L., Lee J., Lu P., Smith K., Browne S., Beal M.F., et al. Chemotherapy for the brain: The antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington&#x2019;s disease. J. Neurosci. 2004;24:10335&#x2013;10342. doi: 10.1523/JNEUROSCI.2599-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2599-04.2004</ArticleId><ArticleId IdType="pmc">PMC2577231</ArticleId><ArticleId IdType="pubmed">15548647</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardian G., Browne S.E., Choi D.-K., Klivenyi P., Gregorio J., Kubilus J.K., Ryu H., Langley B., Ratan R.R., Ferrante R.J., et al. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington&#x2019;s disease. J. Biol. Chem. 2005;280:556&#x2013;563. doi: 10.1074/jbc.M410210200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M410210200</ArticleId><ArticleId IdType="pubmed">15494404</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea S., Eisenhaber F., O&#x2019;Carroll D., Strahl B.D., Sun Z.-W., Schmid M., Opravil S., Mechtler K., Ponting C.P., Allis C.D., et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 2000;406:593&#x2013;599. doi: 10.1038/35020506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35020506</ArticleId><ArticleId IdType="pubmed">10949293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu H., Lee J., Hagerty S.W., Soh B.Y., McAlpin S.E., Cormier K.A., Smith K.M., Ferrante R.J. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2006;103:19176&#x2013;19181. doi: 10.1073/pnas.0606373103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606373103</ArticleId><ArticleId IdType="pmc">PMC1748195</ArticleId><ArticleId IdType="pubmed">17142323</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadri-Vakili G., Cha J.H. Mechanisms of disease: Histone modifications in Huntington&#x2019;s disease. Nat. Clin. Pract. Neurol. 2006;2:330&#x2013;338. doi: 10.1038/ncpneuro0199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneuro0199</ArticleId><ArticleId IdType="pubmed">16932577</ArticleId></ArticleIdList></Reference><Reference><Citation>Stack E.C., Del Signore S.J., Luthi-Carter R., Soh B.Y., Goldstein D.R., Matson S., Goodrich S., Markey A.L., Cormier K., Hagerty S.W., et al. Modulation of nucleosome dynamics in Huntington&#x2019;s disease. Hum. Mol. Genet. 2007;16:1164&#x2013;1175. doi: 10.1093/hmg/ddm064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm064</ArticleId><ArticleId IdType="pubmed">17403718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hagerty S., Cormier K.A., Kim J., Kung A.L., Ferrante R.J., Ryu H. Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation. Hum. Mol. Genet. 2008;17:1774&#x2013;1782. doi: 10.1093/hmg/ddn067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn067</ArticleId><ArticleId IdType="pmc">PMC2900890</ArticleId><ArticleId IdType="pubmed">18319327</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R., Terry A.V., Singh P.B., Gilbert D.M. Differential subnuclear localization and replication timing of histone H3 lysine 9 methylation states. Mol. Biol. Cell. 2005;16:2872&#x2013;2881. doi: 10.1091/mbc.e04-11-0997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-11-0997</ArticleId><ArticleId IdType="pmc">PMC1142431</ArticleId><ArticleId IdType="pubmed">15788566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T., Arbez N., Stewart J.C., Chighladze E., A Ross C. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington&#x2019;s disease (HD) Cell Cycle. 2015;14:1716&#x2013;1729. doi: 10.1080/15384101.2015.1033595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2015.1033595</ArticleId><ArticleId IdType="pmc">PMC4615115</ArticleId><ArticleId IdType="pubmed">25927346</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong I.S., Woda J.M., Song J.-J., Lloret A., Abeyrathne P.D., Woo C.J., Gregory G., Lee J.-M., Wheeler V.C., Walz T., et al. Huntingtin facilitates polycomb repressive complex 2. Hum. Mol. Genet. 2010;19:573&#x2013;583. doi: 10.1093/hmg/ddp524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp524</ArticleId><ArticleId IdType="pmc">PMC2807366</ArticleId><ArticleId IdType="pubmed">19933700</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda S., Mas G., Di Croce L. Regulation of gene transcription by Polycomb proteins. Sci. Adv. 2015;1:e1500737. doi: 10.1126/sciadv.1500737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1500737</ArticleId><ArticleId IdType="pmc">PMC4672759</ArticleId><ArticleId IdType="pubmed">26665172</ArticleId></ArticleIdList></Reference><Reference><Citation>Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469:343&#x2013;349. doi: 10.1038/nature09784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09784</ArticleId><ArticleId IdType="pmc">PMC3760771</ArticleId><ArticleId IdType="pubmed">21248841</ArticleId></ArticleIdList></Reference><Reference><Citation>Biagioli M., Ferrari F., Mendenhall E.M., Zhang Y., Erdin S., Vijayvargia R., Vallabh S.M., Solomos N., Manavalan P., Ragavendran A., et al. Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. Hum. Mol. Genet. 2015;24:2442&#x2013;2457. doi: 10.1093/hmg/ddv006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv006</ArticleId><ArticleId IdType="pmc">PMC4383859</ArticleId><ArticleId IdType="pubmed">25574027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.-H., Sharma A., Dhar S.S., Lee S.-H., Gu B., Chan C.-H., Lin H.-K., Lee M.G. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells. Cancer Res. 2014;74:1705&#x2013;1717. doi: 10.1158/0008-5472.CAN-13-1896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-13-1896</ArticleId><ArticleId IdType="pmc">PMC3962500</ArticleId><ArticleId IdType="pubmed">24491801</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X., Tsuji J., Labadorf A., Roussos P., Chen J.-F., Myers R.H., Akbarian S., Weng Z. The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington&#x2019;s Disease. PLoS ONE. 2015;10:e0144398. doi: 10.1371/journal.pone.0144398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0144398</ArticleId><ArticleId IdType="pmc">PMC4670094</ArticleId><ArticleId IdType="pubmed">26636336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoss A.G., Kartha V.K., Dong X., Latourelle J.C., Dumitriu A., Hadzi T.C., Macdonald M.E., Gusella J.F., Akbarian S., Chen J.-F., et al. MicroRNAs located in the Hox gene clusters are implicated in huntington&#x2019;s disease pathogenesis. PLoS Genet. 2014;10:e1004188. doi: 10.1371/journal.pgen.1004188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004188</ArticleId><ArticleId IdType="pmc">PMC3937267</ArticleId><ArticleId IdType="pubmed">24586208</ArticleId></ArticleIdList></Reference><Reference><Citation>Labadorf A., Hoss A.G., Lagomarsino V., Latourelle J.C., Hadzi T.C., Bregu J., MacDonald M.E., Gusella J.F., Chen J.F., Akbarian S., et al. RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression. PLoS ONE. 2015;10:e0143563. doi: 10.1371/journal.pone.0143563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0143563</ArticleId><ArticleId IdType="pmc">PMC4670106</ArticleId><ArticleId IdType="pubmed">26636579</ArticleId></ArticleIdList></Reference><Reference><Citation>Labadorf A.T., Myers R.H. Evidence of Extensive Alternative Splicing in Post Mortem Human Brain HTT Transcription by mRNA Sequencing. PLoS ONE. 2015;10:e0141298. doi: 10.1371/journal.pone.0141298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0141298</ArticleId><ArticleId IdType="pmc">PMC4619731</ArticleId><ArticleId IdType="pubmed">26496077</ArticleId></ArticleIdList></Reference><Reference><Citation>von Schimmelmann M., Feinberg P.A., Sullivan J.M., Ku S.M., Badimon A., Duff M.K., Wang Z., Lachmann A., Dewell S., Ma&#x2019;ayan A., et al. Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration. Nat. Neurosci. 2016;19:1321&#x2013;1330. doi: 10.1038/nn.4360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4360</ArticleId><ArticleId IdType="pmc">PMC5088783</ArticleId><ArticleId IdType="pubmed">27526204</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini D., Hansen K.H., Christensen J., Agger K., Cloos P.A., Helin K. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes. Dev. 2008;22:1345&#x2013;1355. doi: 10.1101/gad.470008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.470008</ArticleId><ArticleId IdType="pmc">PMC2377189</ArticleId><ArticleId IdType="pubmed">18483221</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashishtha M., Ng C.W., Yildirim F., Gipson T.A., Kratter I.H., Bodai L., Song W., Lau A.L., Labadorf A., Vogel-Ciernia A., et al. Targeting H3K4 trimethylation in Huntington disease. Proc. Natl. Acad. Sci. USA. 2013;110:E3027&#x2013;E3036. doi: 10.1073/pnas.1311323110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1311323110</ArticleId><ArticleId IdType="pmc">PMC3740882</ArticleId><ArticleId IdType="pubmed">23872847</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccato C., Cattaneo E. Role of brain-derived neurotrophic factor in Huntington&#x2019;s disease. Prog. Neurobiol. 2007;81:294&#x2013;330. doi: 10.1016/j.pneurobio.2007.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2007.01.003</ArticleId><ArticleId IdType="pubmed">17379385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccato C., Ciammola A., Rigamonti D., Leavitt B.R., Goffredo D., Conti L., Macdonald M.E., Friedlander R.M., Silani V., Hayden M.R., et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington&#x2019;s disease. Science. 2001;293:493&#x2013;498. doi: 10.1126/science.1059581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1059581</ArticleId><ArticleId IdType="pubmed">11408619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A., Goldstein D.R., Hodges A., Strand A.D., Sengstag T., Kooperberg C., Becanovic K., Pouladi M.A., Sathasivam K., Cha J.J., et al. Mutant huntingtin&#x2019;s effects on striatal gene expression in mice recapitulate changes observed in human Huntington&#x2019;s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum. Mol. Genet. 2007;16:1845&#x2013;1861. doi: 10.1093/hmg/ddm133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm133</ArticleId><ArticleId IdType="pubmed">17519223</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai G., Cheung I., Shulha H.P., Coelho J.E., Li P., Dong X., Jakovcevski M., Wang Y., Grigorenko A., Jiang Y., et al. Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains. Hum. Mol. Genet. 2015;24:1441&#x2013;1456. doi: 10.1093/hmg/ddu561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu561</ArticleId><ArticleId IdType="pmc">PMC4321450</ArticleId><ArticleId IdType="pubmed">25480889</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald J.C., Plun-Favreau H. Emerging pathways in genetic Parkinson&#x2019;s disease: Autosomal-recessive genes in Parkinson&#x2019;s disease&#x2014;A common pathway? FEBS J. 2008;275:5758&#x2013;5766. doi: 10.1111/j.1742-4658.2008.06708.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2008.06708.x</ArticleId><ArticleId IdType="pubmed">19021753</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovic J. Parkinson&#x2019;s disease: Clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry. 2008;79:368&#x2013;376. doi: 10.1136/jnnp.2007.131045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.131045</ArticleId><ArticleId IdType="pubmed">18344392</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F., Tanji K., Zhang H., Kakita A., Takahashi H., Wakabayashi K. Alpha-Synuclein pathology in the neostriatum in Parkinson&#x2019;s disease. Acta Neuropathol. 2008;115:453&#x2013;459. doi: 10.1007/s00401-007-0316-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0316-4</ArticleId><ArticleId IdType="pubmed">18000672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K., Tanji K., Mori F., Takahashi H. The Lewy body in Parkinson&#x2019;s disease: Molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology. 2007;27:494&#x2013;506. doi: 10.1111/j.1440-1789.2007.00803.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2007.00803.x</ArticleId><ArticleId IdType="pubmed">18018486</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee P., Roy D., Bhattacharyya M., Bandyopadhyay S. Biological networks in Parkinson&#x2019;s disease: An insight into the epigenetic mechanisms associated with this disease. BMC Genom. 2017;18:721. doi: 10.1186/s12864-017-4098-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-017-4098-3</ArticleId><ArticleId IdType="pmc">PMC5596942</ArticleId><ArticleId IdType="pubmed">28899360</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Jankovic J., Wu Y.C. Epigenetic mechanisms in Parkinson&#x2019;s disease. J. Neurol. Sci. 2015;349:3&#x2013;9. doi: 10.1016/j.jns.2014.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.12.017</ArticleId><ArticleId IdType="pubmed">25553963</ArticleId></ArticleIdList></Reference><Reference><Citation>Labbe C., Lorenzo-Betancor O., Ross O.A. Epigenetic regulation in Parkinson&#x2019;s disease. Acta Neuropathol. 2016;132:515&#x2013;530. doi: 10.1007/s00401-016-1590-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1590-9</ArticleId><ArticleId IdType="pmc">PMC5026906</ArticleId><ArticleId IdType="pubmed">27358065</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Heesbeen H.J., Smidt M.P. Entanglement of Genetics and Epigenetics in Parkinson&#x2019;s Disease. Front. Neurosci. 2019;13:277. doi: 10.3389/fnins.2019.00277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00277</ArticleId><ArticleId IdType="pmc">PMC6449477</ArticleId><ArticleId IdType="pubmed">30983962</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugeno N., J&#xe4;ckel S., Voigt A., Wassouf Z., Schulze-Hentrich J., Kahle P.J. Alpha-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses. Sci. Rep. 2016;6:36328. doi: 10.1038/srep36328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep36328</ArticleId><ArticleId IdType="pmc">PMC5093762</ArticleId><ArticleId IdType="pubmed">27808254</ArticleId></ArticleIdList></Reference><Reference><Citation>Guhathakurta S., Kim J., Adams L., Basu S., Song M.K., Adler E., Je G., Fiadeiro M.B., Kim Y. Targeted attenuation of elevated histone marks at SNCA alleviates alpha-synuclein in Parkinson&#x2019;s disease. EMBO Mol. Med. 2021;13:e12188. doi: 10.15252/emmm.202012188.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202012188</ArticleId><ArticleId IdType="pmc">PMC7863397</ArticleId><ArticleId IdType="pubmed">33428332</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu M.-D., Qian Z.-M., Yang S.-X., Rong K.-L., Yung W.-H., Ke Y. Therapeutic effect of a histone demethylase inhibitor in Parkinson&#x2019;s disease. Cell Death Dis. 2020;11:927. doi: 10.1038/s41419-020-03105-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-03105-5</ArticleId><ArticleId IdType="pmc">PMC7595123</ArticleId><ArticleId IdType="pubmed">33116116</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinemann B., Nielsen J.M., Hudlebusch H.R., Lees M.J., Larsen D.V., Boesen T., Labelle M., Gerlach L.-O., Birk P., Helin K. Inhibition of demethylases by GSK-J1/J4. Nature. 2014;514:E1&#x2013;E2. doi: 10.1038/nature13688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13688</ArticleId><ArticleId IdType="pubmed">25279926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruidenier L., Chung C.-W., Cheng Z., Liddle J., Che K., Joberty G., Bantscheff M., Bountra C., Bridges A., Diallo H., et al. Kruidenier et al. reply. Nature. 2014;514:E2. doi: 10.1038/nature13689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13689</ArticleId><ArticleId IdType="pubmed">25279927</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang S.Y.-Y., Hsu J.S., Teo K.-C., Li Y., Kung M.H., Cheah K.S., Chan D., Cheung K.M., Li M., Sham P.-C., et al. Burden of rare variants in ALS genes influences survival in familial and sporadic ALS. Neurobiol. Aging. 2017;58:238.e9&#x2013;238.e15. doi: 10.1016/j.neurobiolaging.2017.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.06.007</ArticleId><ArticleId IdType="pubmed">28709720</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S., Carr K., Reiley L., Diaz K., Guerra O., Altamirano P.F., Pagani W., Lodin D., Orozco G., Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surg. Neurol. Int. 2015;6:171. doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Stetkarova I., Ehler E. Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date. Diagnostics. 2021;11:231. doi: 10.3390/diagnostics11020231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11020231</ArticleId><ArticleId IdType="pmc">PMC7913557</ArticleId><ArticleId IdType="pubmed">33546386</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil V.V., Katzman R.B., Petrucelli L. ALS and FTD: An epigenetic perspective. Acta Neuropathol. 2016;132:487&#x2013;502. doi: 10.1007/s00401-016-1587-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1587-4</ArticleId><ArticleId IdType="pmc">PMC5138862</ArticleId><ArticleId IdType="pubmed">27282474</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A., Wicklund M.P. Amyotrophic lateral sclerosis: What role does environment play? Neurol. Clin. 2011;29:689&#x2013;711. doi: 10.1016/j.ncl.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2011.06.001</ArticleId><ArticleId IdType="pubmed">21803219</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Kwak S., Mehler M., Rouleau G., Siddique T., Strong M., Leigh P.N. Genetic and epigenetic studies of amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 2013;14:44&#x2013;52. doi: 10.3109/21678421.2013.778571.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778571</ArticleId><ArticleId IdType="pubmed">23678879</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>He F., Todd P.K. Epigenetics in nucleotide repeat expansion disorders. Semin. Neurol. 2011;31:470&#x2013;483. doi: 10.1055/s-0031-1299786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1299786</ArticleId><ArticleId IdType="pmc">PMC3655547</ArticleId><ArticleId IdType="pubmed">22266885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebbert M.T.W., Lank R.J., Belzil V.V. An Epigenetic Spin to ALS and FTD. Adv. Neurobiol. 2018;20:1&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">29916014</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil V.V., Bauer P.O., Prudencio M., Gendron T.F., Stetler C.T., Yan I.K., Pregent L., Daughrity L., Baker M.C., Rademakers R., et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895&#x2013;905. doi: 10.1007/s00401-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Esanov R., Cabrera G.T., Andrade N.S., Gendron T.F., Brown R.H., Benatar M., Wahlestedt C., Mueller C., Zeier Z. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD. Mol. Neurodegener. 2017;12:46. doi: 10.1186/s13024-017-0185-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0185-9</ArticleId><ArticleId IdType="pmc">PMC5468954</ArticleId><ArticleId IdType="pubmed">28606110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jury N., Abarzua S., Diaz I., Guerra M.V., Ampuero E., Cubillos P., Martinez P., Herrera-Soto A., Arredondo C., Rojas F., et al. Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice. Clin. Epigenetics. 2020;12:32. doi: 10.1186/s13148-020-0816-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-020-0816-9</ArticleId><ArticleId IdType="pmc">PMC7029485</ArticleId><ArticleId IdType="pubmed">32070418</ArticleId></ArticleIdList></Reference><Reference><Citation>Gary J.D., Lin W.-J., Yang M.C., Herschman H.R., Clarke S. The predominant protein-arginine methyltransferase from Saccharomyces cerevisiae. J. Biol. Chem. 1996;271:12585&#x2013;12594. doi: 10.1074/jbc.271.21.12585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.21.12585</ArticleId><ArticleId IdType="pubmed">8647869</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrozza M.J., Li B., Florens L., Suganuma T., Swanson S.K., Lee K.K., Shia W.-J., Anderson S., Yates J., Washburn M.P., et al. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell. 2005;123:581&#x2013;592. doi: 10.1016/j.cell.2005.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.10.023</ArticleId><ArticleId IdType="pubmed">16286007</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A.A., Struhl K. Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation. Mol. Cell. 2005;20:971&#x2013;978. doi: 10.1016/j.molcel.2005.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.11.021</ArticleId><ArticleId IdType="pubmed">16364921</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun M.H., Ryu H.H., Jun Y.W., Liu T., Li Y., Lim C.S., Lee Y.S., Kaang B.K., Jang D.J., Lee J.A. Sequestration of PRMT1 and Nd1-L mRNA into ALS-linked FUS mutant R521C-positive aggregates contributes to neurite degeneration upon oxidative stress. Sci Rep. 2017;7:40474. doi: 10.1038/srep40474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep40474</ArticleId><ArticleId IdType="pmc">PMC5240339</ArticleId><ArticleId IdType="pubmed">28094300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani M., Tradewell M.L., Mattina K.R., Minotti S., Yang W., Zhou H., Strong M.J., Hayward L.J., Durham H.D. Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. Hum. Mol. Genet. 2015;24:773&#x2013;786. doi: 10.1093/hmg/ddu494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu494</ArticleId><ArticleId IdType="pmc">PMC4291251</ArticleId><ArticleId IdType="pubmed">25274782</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Chen H.J., Shaw C.E. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics. 2015;12:352&#x2013;363. doi: 10.1007/s13311-015-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyadjieva N.I., Sarkar D.K. Role of microglia in ethanol&#x2019;s apoptotic action on hypothalamic neuronal cells in primary cultures. Alcohol Clin. Exp. Res. 2010;34:1835&#x2013;1842. doi: 10.1111/j.1530-0277.2010.01271.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1530-0277.2010.01271.x</ArticleId><ArticleId IdType="pmc">PMC2965273</ArticleId><ArticleId IdType="pubmed">20662807</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun K., Bayarsaikhan D., Bayarsaikhan E., Son M., Oh S., Lee J., Son H.-I., Won M.-H., Kim S.U., Song B.-J., et al. Microglial AGE-albumin is critical in promoting alcohol-induced neurodegeneration in rats and humans. PLoS ONE. 2014;9:e104699. doi: 10.1371/journal.pone.0104699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104699</ArticleId><ArticleId IdType="pmc">PMC4139297</ArticleId><ArticleId IdType="pubmed">25140518</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall S.A., McClain J.A., Kelso M.L., Hopkins D.M., Pauly J.R., Nixon K. Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype. Neurobiol. Dis. 2013;54:239&#x2013;251. doi: 10.1016/j.nbd.2012.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.12.016</ArticleId><ArticleId IdType="pmc">PMC3629000</ArticleId><ArticleId IdType="pubmed">23313316</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbanna S., Shivakumar M., Psychoyos D., Xie S., Basavarajappa B.S. Anandamide-CB1 Receptor Signaling Contributes to Postnatal Ethanol-Induced Neonatal Neurodegeneration, Adult Synaptic and Memory Deficits. J. Neurosci. 2013;33:6350&#x2013;6366. doi: 10.1523/JNEUROSCI.3786-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3786-12.2013</ArticleId><ArticleId IdType="pmc">PMC3742029</ArticleId><ArticleId IdType="pubmed">23575834</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateno M., Saito T. Biological studies on alcohol-induced neuronal damage. Psychiatry Investig. 2008;5:21&#x2013;27. doi: 10.4306/pi.2008.5.1.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4306/pi.2008.5.1.21</ArticleId><ArticleId IdType="pmc">PMC2796092</ArticleId><ArticleId IdType="pubmed">20046404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.-N., Wang F., Fan Y.-X., Ping G.-F., Yang J.-Y., Wu C.-F. Activated microglia are implicated in cognitive deficits, neuronal death, and successful recovery following intermittent ethanol exposure. Behav. Brain Res. 2013;236:270&#x2013;282. doi: 10.1016/j.bbr.2012.08.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2012.08.052</ArticleId><ArticleId IdType="pubmed">22985845</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkel T.D., Pandey S.C. Emerging Role of Epigenetic Mechanisms in Alcohol Addiction. Alcohol Clin. Exp. Res. 2017;41:666&#x2013;680. doi: 10.1111/acer.13338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.13338</ArticleId><ArticleId IdType="pmc">PMC5378655</ArticleId><ArticleId IdType="pubmed">28111764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciafr&#xe8; S., Carito V., Ferraguti G., Greco A., Chaldakov G.N., Fiore M., Ceccanti M. How alcohol drinking affects our genes: An epigenetic point of view. Biochem. Cell. Biol. 2019;97:345&#x2013;356. doi: 10.1139/bcb-2018-0248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/bcb-2018-0248</ArticleId><ArticleId IdType="pubmed">30412425</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmisano M., Pandey S.C. Epigenetic mechanisms of alcoholism and stress-related disorders. Alcohol. 2017;60:7&#x2013;18. doi: 10.1016/j.alcohol.2017.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alcohol.2017.01.001</ArticleId><ArticleId IdType="pmc">PMC5464725</ArticleId><ArticleId IdType="pubmed">28477725</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnsack J.P., Pandey S.C. Histone modifications, DNA methylation, and the epigenetic code of alcohol use disorder. Int. Rev. Neurobiol. 2021;156:1&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7990320</ArticleId><ArticleId IdType="pubmed">33461661</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Yuan Q., Mash D.C., Goldman D. Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol. Proc. Natl. Acad. Sci. USA. 2011;108:6626&#x2013;6631. doi: 10.1073/pnas.1018514108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1018514108</ArticleId><ArticleId IdType="pmc">PMC3081016</ArticleId><ArticleId IdType="pubmed">21464311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponomarev I., Wang S., Zhang L., Harris R.A., Mayfield R.D. Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence. J. Neurosci. 2012;32:1884&#x2013;1897. doi: 10.1523/JNEUROSCI.3136-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3136-11.2012</ArticleId><ArticleId IdType="pmc">PMC3564514</ArticleId><ArticleId IdType="pubmed">22302827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnsack J.P., Teppen T., Kyzar E.J., Dzitoyeva S., Pandey S.C. The lncRNA BDNF-AS is an epigenetic regulator in the human amygdala in early onset alcohol use disorders. Transl. Psychiatry. 2019;9:34. doi: 10.1038/s41398-019-0367-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0367-z</ArticleId><ArticleId IdType="pmc">PMC6365546</ArticleId><ArticleId IdType="pubmed">30728347</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnstone A.L., Andrade N.S., Barbier E., Khomtchouk B.B., Rienas C.A., Lowe K., Van Booven D.J., Domi E., Esanov R., Vilca S., et al. Dysregulation of the histone demethylase KDM6B in alcohol dependence is associated with epigenetic regulation of inflammatory signaling pathways. Addict. Biol. 2021;26:e12816. doi: 10.1111/adb.12816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/adb.12816</ArticleId><ArticleId IdType="pmc">PMC7757263</ArticleId><ArticleId IdType="pubmed">31373129</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegersh A., Homanics G.A. Acute ethanol alters multiple histone modifications at model gene promoters in the cerebral cortex. Alcohol Clin. Exp. Res. 2014;38:1865&#x2013;1873. doi: 10.1111/acer.12465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.12465</ArticleId><ArticleId IdType="pmc">PMC4107049</ArticleId><ArticleId IdType="pubmed">24942484</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Addario C., Caputi F.F., Ekstr&#xf6;m T.J., Di Benedetto M., Maccarrone M., Romualdi P., Candeletti S. Ethanol induces epigenetic modulation of prodynorphin and pronociceptin gene expression in the rat amygdala complex. J. Mol. Neurosci. 2013;49:312&#x2013;319. doi: 10.1007/s12031-012-9829-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-012-9829-y</ArticleId><ArticleId IdType="pubmed">22684622</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Addario C., Caputi F.F., Rimondini R., Gandolfi O., Del Borrello E., Candeletti S., Romualdi P. Different alcohol exposures induce selective alterations on the expression of dynorphin and nociceptin systems related genes in rat brain. Addict. Biol. 2013;18:425&#x2013;433. doi: 10.1111/j.1369-1600.2011.00326.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1369-1600.2011.00326.x</ArticleId><ArticleId IdType="pubmed">21507157</ArticleId></ArticleIdList></Reference><Reference><Citation>Stragier E., Massart R., Salery M., Hamon M., Geny D., Martin V., Boulle F., Lanfumey L. Ethanol-induced epigenetic regulations at the Bdnf gene in C57BL/6J mice. Mol. Psychiatry. 2015;20:405&#x2013;412. doi: 10.1038/mp.2014.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2014.38</ArticleId><ArticleId IdType="pubmed">24776738</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiang M., Denny A., Lieu M., Carreon S., Li J. Histone H3K9 modifications are a local chromatin event involved in ethanol-induced neuroadaptation of the NR2B gene. Epigenetics. 2011;6:1095&#x2013;1104. doi: 10.4161/epi.6.9.16924.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/epi.6.9.16924</ArticleId><ArticleId IdType="pmc">PMC3225745</ArticleId><ArticleId IdType="pubmed">21814037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual M., Couto B.R.D., Alfonso-Loeches S., Aguilar M.A., Rodriguez-Arias M., Guerri C. Changes in histone acetylation in the prefrontal cortex of ethanol-exposed adolescent rats are associated with ethanol-induced place conditioning. Neuropharmacology. 2012;62:2309&#x2013;2319. doi: 10.1016/j.neuropharm.2012.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2012.01.011</ArticleId><ArticleId IdType="pubmed">22349397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyzar E.J., Zhang H., Sakharkar A.J., Pandey S.C. Adolescent alcohol exposure alters lysine demethylase 1 (LSD1) expression and histone methylation in the amygdala during adulthood. Addict. Biol. 2017;22:1191&#x2013;1204. doi: 10.1111/adb.12404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/adb.12404</ArticleId><ArticleId IdType="pmc">PMC5110402</ArticleId><ArticleId IdType="pubmed">27183824</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbier E., Johnstone A.L., Khomtchouk B.B., Tapocik J.D., Pitcairn C., Rehman F., Augier E., Borich A., Schank J.R., Rienas C.A., et al. Dependence-induced increase of alcohol self-administration and compulsive drinking mediated by the histone methyltransferase PRDM2. Mol. Psychiatry. 2017;22:1746&#x2013;1758. doi: 10.1038/mp.2016.131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.131</ArticleId><ArticleId IdType="pmc">PMC5677579</ArticleId><ArticleId IdType="pubmed">27573876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolstenholme J.T., Mahmood T., Harris G.M., Abbas S., Miles M.F. Intermittent Ethanol during Adolescence Leads to Lasting Behavioral Changes in Adulthood and Alters Gene Expression and Histone Methylation in the PFC. Front. Mol. Neurosci. 2017;10:307. doi: 10.3389/fnmol.2017.00307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00307</ArticleId><ArticleId IdType="pmc">PMC5622951</ArticleId><ArticleId IdType="pubmed">29018328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavin D.P., Hashimoto J.G., Lazar N.H., Carbone L., Crabbe J.C., Guizzetti M. Stable Histone Methylation Changes at Proteoglycan Network Genes Following Ethanol Exposure. Front. Genet. 2018;9:346. doi: 10.3389/fgene.2018.00346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00346</ArticleId><ArticleId IdType="pmc">PMC6125400</ArticleId><ArticleId IdType="pubmed">30214456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyzar E.J., Zhang H., Pandey S.C. Adolescent Alcohol Exposure Epigenetically Suppresses Amygdala Arc Enhancer RNA Expression to Confer Adult Anxiety Susceptibility. Biol. Psychiatry. 2019;85:904&#x2013;914. doi: 10.1016/j.biopsych.2018.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2018.12.021</ArticleId><ArticleId IdType="pmc">PMC6684056</ArticleId><ArticleId IdType="pubmed">30827484</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto J.G., Gavin D.P., Wiren K.M., Crabbe J.C., Guizzetti M. Prefrontal cortex expression of chromatin modifier genes in male WSP and WSR mice changes across ethanol dependence, withdrawal, and abstinence. Alcohol. 2017;60:83&#x2013;94. doi: 10.1016/j.alcohol.2017.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alcohol.2017.01.010</ArticleId><ArticleId IdType="pmc">PMC5497775</ArticleId><ArticleId IdType="pubmed">28433423</ArticleId></ArticleIdList></Reference><Reference><Citation>Veazey K.J., Parnell S.E., Miranda R.C., Golding M.C. Dose-dependent alcohol-induced alterations in chromatin structure persist beyond the window of exposure and correlate with fetal alcohol syndrome birth defects. Epigenetics Chromatin. 2015;8:39. doi: 10.1186/s13072-015-0031-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-015-0031-7</ArticleId><ArticleId IdType="pmc">PMC4587584</ArticleId><ArticleId IdType="pubmed">26421061</ArticleId></ArticleIdList></Reference><Reference><Citation>Govorko D., Bekdash R.A., Zhang C., Sarkar D.K. Male germline transmits fetal alcohol adverse effect on hypothalamic proopiomelanocortin gene across generations. Biol. Psychiatry. 2012;72:378&#x2013;388. doi: 10.1016/j.biopsych.2012.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2012.04.006</ArticleId><ArticleId IdType="pmc">PMC3414692</ArticleId><ArticleId IdType="pubmed">22622000</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekdash R.A., Zhang C., Sarkar D.K. Gestational Choline Supplementation Normalized Fetal Alcohol-Induced Alterations in Histone Modifications, DNA Methylation, and Proopiomelanocortin (POMC) Gene Expression in beta-Endorphin-Producing POMC Neurons of the Hypothalamus. Alcohol Clin. Exp. Res. 2013;37:1133&#x2013;1142. doi: 10.1111/acer.12082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.12082</ArticleId><ArticleId IdType="pmc">PMC3659188</ArticleId><ArticleId IdType="pubmed">23413810</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbanna S., Nagre N.N., Shivakumar M., Umapathy N.S., Psychoyos D., Basavarajappa B.S. Ethanol induced acetylation of histone at G9a exon1 and G9a-mediated histone H3 dimethylation leads to neurodegeneration in neonatal mice. Neuroscience. 2014;258:422&#x2013;432. doi: 10.1016/j.neuroscience.2013.11.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.11.043</ArticleId><ArticleId IdType="pmc">PMC3954640</ArticleId><ArticleId IdType="pubmed">24300108</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbanna S., Basavarajappa B.S. Pre-administration of G9a/GLP inhibitor during Synaptogenesis Prevents Postnatal Ethanol-induced LTP Deficits and Neurobehavioral Abnormalities in Adult Mice. Exp. Neurol. 2014;261:34&#x2013;43. doi: 10.1016/j.expneurol.2014.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.07.003</ArticleId><ArticleId IdType="pmc">PMC4194267</ArticleId><ArticleId IdType="pubmed">25017367</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbanna S., Joshi V., Basavarajappa B.S. Activity-dependent Signaling and Epigenetic Abnormalities in Mice Exposed to Postnatal Ethanol. Neuroscience. 2018;392:230&#x2013;240. doi: 10.1016/j.neuroscience.2018.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.07.011</ArticleId><ArticleId IdType="pmc">PMC6204293</ArticleId><ArticleId IdType="pubmed">30031835</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi V., Subbanna S., Shivakumar M., Basavarajappa B.S. CB1R regulates CDK5 signaling and epigenetically controls Rac1 expression contributing to neurobehavioral abnormalities in mice postnatally exposed to ethanol. Neuropsychopharmacology. 2019;44:514&#x2013;525. doi: 10.1038/s41386-018-0181-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-018-0181-y</ArticleId><ArticleId IdType="pmc">PMC6333777</ArticleId><ArticleId IdType="pubmed">30143782</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbanna S., Nagre N.N., Umapathy N.S., Pace B.S., Basavarajappa B.S. Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice. Int. J. Neuropsychopharmacol. 2015;18:1&#x2013;15. doi: 10.1093/ijnp/pyu028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijnp/pyu028</ArticleId><ArticleId IdType="pmc">PMC4376538</ArticleId><ArticleId IdType="pubmed">25609594</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C.R., Ho M.-F., Vega M.C.S., Burne T.H.J., Chong S. Prenatal ethanol exposure alters adult hippocampal VGLUT2 expression with concomitant changes in promoter DNA methylation, H3K4 trimethylation and miR-467b-5p levels. Epigenetics Chromatin. 2015;8:40. doi: 10.1186/s13072-015-0032-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-015-0032-6</ArticleId><ArticleId IdType="pmc">PMC4587775</ArticleId><ArticleId IdType="pubmed">26421062</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarmasz J.S., Stirton H., Basalah D., Davie J.R., Clarren S.K., Astley S.J., Del Bigio M.R. Global DNA Methylation and Histone Posttranslational Modifications in Human and Nonhuman Primate Brain in Association with Prenatal Alcohol Exposure. Alcohol Clin. Exp. Res. 2019;43:1145&#x2013;1162. doi: 10.1111/acer.14052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.14052</ArticleId><ArticleId IdType="pmc">PMC6593679</ArticleId><ArticleId IdType="pubmed">31074890</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaffner S.L., Lussier A.A., Baker J.A., Goldowitz D., Hamre K.M., Kobor M.S. Neonatal Alcohol Exposure in Mice Induces Select Differentiation- and Apoptosis-Related Chromatin Changes Both Independent of and Dependent on Sex. Front. Genet. 2020;11:35. doi: 10.3389/fgene.2020.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.00035</ArticleId><ArticleId IdType="pmc">PMC7026456</ArticleId><ArticleId IdType="pubmed">32117449</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>